Insightec Ltd. received U.S. FDA approval for use of its Exablate Neuro device to address severe motor symptoms in patients with Parkinson’s disease, offering a new option for patients who have not found adequate relief from medications. Exablate Neuro uses focused ultrasound to create lesions in the brain without requiring an incision or implant. Read More

Patent reform in the U.S. revolves largely around the subject matter eligibility question, but Congress is reluctant to intervene – a predicament addressed recently by Andrei Iancu, formerly the director of the U.S. Patent and Trademark Office. Read More

Glucomodicum Oy reported positive results from a clinical study in which its needle-free continuous glucose monitor, Talisman, was tested in participants across both standard multi-hour glucose tolerance and ambulatory conditions involving exercise and meals. Read More

The U.S. Centers for Medicare & Medicaid Services indicated it will act on a previous proposal to terminate the Treatment Choices Model for ESRD at the end of the current calendar year because of a failure of the program to deliver on the promised efficiencies and improvement in outcomes. Read More

Representatives of patients’ groups, industry bodies and venture philanthropy funders are calling for a renewal of the U.K. Rare Diseases Framework, to put fresh momentum behind translational research and clinical trials, streamline regulatory oversight and improve access to therapies. Read More

The med-tech sector raised $16.46 billion in the first half of 2025, an 18% increase over the $13.94 billion raised during the same period in 2024. Read More

New hires and promotions in the med-tech industry, including: BD, Cathvision, Elucid, Koru Medical, Like Minded Labs, Medtronic. Read More

Med-tech firms raising money in public or private financings, including: Comphya. Read More

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Angle. Read More

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Akoya, Biotronik, Ceribell, Companion Spine, Fotofinder, Glucotrack, Lifeforce, Natus, Osteotec, Paradigm Spine, Quanterix, Samsung, Teleflex, Toku, Ulrich, Xtant Medical. Read More

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Fziomed, Insightec. Read More